⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of VEM Pharmaceuticals (Vem İlaç Sanayi ve Ticaret A.Ş.) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
VEM Pharmaceuticals is a leading Turkish pharmaceutical company established in 2000, specializing in the manufacturing of finished pharmaceutical products. The company operates high-tech production facilities in Turkey, designed to meet international regulatory standards, and provides a wide range of medications across various therapeutic areas including nephrology, oncology, cardiology, and anesthesiology.
The company is recognized for its commitment to local production and sustainable growth, offering diverse dosage forms such as vials, ampoules, pre-filled syringes, lyophilized products, and ophthalmic solutions. VEM Pharmaceuticals actively collaborates with international partners and maintains a strong presence in both the Turkish and international pharmaceutical markets.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:2000
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Injectables, Ophthalmic solutions
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various international pharmaceutical companies for technology transfer and distribution
COMPETITION
Position:Challenger
Competitors:Santa Farma, Polifarma, Abdi Ibrahim, Sanovel, World Medicine
LEADERSHIP
Key Executives:
Cemal Senol - Production Director
Uğur Babuccu - Research And Development Manager
LINKS
Website:vemilac.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with VEM Pharmaceuticals (Vem İlaç Sanayi ve Ticaret A.Ş.). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.